Clinical trial
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving…
NCT00327535 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00327535 |
|---|---|
| Title | A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. |
| Official title | A Multicenter, Randomized, Open Label Dose Finding Study of Mircera in Anemic Patients With Stage IIIB or IV Non-small Cell Lung Cancer Receiving First Line Myelosuppressive Chemotherapy |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 153 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | May 18, 2006 |
| Last update posted | Aug 11, 2016 |
| Countries | Australia, Austria, Belgium, Canada, Czechia, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary and 3 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: